recommended for detection of Ser 363 phosphorylated Rsk-1 of human and rat origin and correspondingly phosphorylated Ser 352 of mouse origin of mouse, rat and human origin by WB and IP
Modification
Phosphoralated
Modification Notes
The family of ribosomal S6 kinases (Rsks), designated Rsk-1, Rsk-2 and Rsk-3, are important signaling intermediates that mediate responses to a broad range of ligand-activated receptor tyrosine kinases. It has been established that Rsk-3 is not activated by MAP kinase in vitro, unlike Rsk-1 and Rsk-2. A unique feature common to the three members of the Rsk family is that each possesses two non-identical complete kinase catalytic domains. The Rsk family amino-terminal kinase domain is phosphorylated on Ser 227 by 3-phosphoinositide-dependent protein kinase-1 (PDK1), which increases the kinase activity of Rsk. In the carboxy-terminal kinase domain, Rsk-1 and Rsk-2 are autophosphorylated on Ser 380 and Ser 386, respectively, which mediates the docking of PDK1 to Rsk in order to promote phosphorylation of substrates, such as histone H3. Human, rat and mouse Rsk-1 are activated by phosphorylation on threonine and serine residues, such as Ser 363.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WB
WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher.
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
recommended for detection of Ser 363 phosphorylated Rsk-1 of human and rat origin and correspondingly phosphorylated Ser 352 of mouse origin of mouse rat and human origin by WB and IP
Tissue Specificity
recommended for detection of Ser 363 phosphorylated Rsk-1 of human and rat origin and correspondingly phosphorylated Ser 352 of mouse origin of mouse, rat and human origin by WB and IP